File(s) not publicly available
Balancing Access to Pharmaceuticals with Patent Rights
It is generally recognised that public health problems in the developing world are dire and that the rest of the world has a moral commitment to provide assistance. Yet many of the world's poor are unable to access essential pharmaceuticals simply because products that are under patent are too expensive and cheaper generics are not available. One of the proposed solutions to this problem is to allow domestic manufacture of generic products in response to health crises. However, this solution will provide no assistance in countries that lack the capacity to manufacture pharmaceuticals. This article discusses the extensive international negotiations occurring during the last couple of years that seek to provide an appropriate balance between access rights and patent rights.
History
Publication title
Monash Bioethics ReviewVolume
22Pagination
50-62ISSN
1321-2753Department/School
Faculty of LawPublisher
Centre for Human Bioethics, Monash UniversityPlace of publication
MelbourneRepository Status
- Restricted